What are the upcoming trends of Autologous Cell Therapy Market in the world?

The growth of global autologous cell therapy market is majorly driven by increase in demand for autologous cell therapy, owing to rise in R&D institutes & organizations for developing autologous cell therapy products and surge in chronic diseases especially cancer

Which is the largest regional market for Autologous Cell Therapy?

North America is the largest regional market for autologous cell therapy

What is autologous cell therapy market growth?

In 2022, the global Autologous Cell Therapy market accounted for USD 5.5 billion. Between 2023 and 2032, this market is estimated to register A CAGR of 20.2%.

Global Autologous Cell Therapy Market By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, and Chondrocytes), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, and Wound Healing), By End-User (Hospitals & Clinics, Ambulatory Centers, and Academics & Research), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 99956
Number of Pages: 341
Format:

- BrainStorm Cell Therapeutics
- Holostem Terapie Avanzate S.R.L
- Pharmicell Co. Inc
- Opexa Therapeutics
- Caladrius Biosciences Inc.
- S. Stem Cell Inc.
- Lonza Group AG Company Profile
- Bristol Myers Squibb Company Profile
- Novartis AG Company Profile
- Autolus therapeutics
- Tego Science
- Corning Inc.
- Bio Elpida
- Vericel Corporation
- Catalent Inc.
- Sartorius AG
- Other Key Players

Related Reports

Our Clients

Report ID 99956
Published Date Oct 2023
Rating
- ★★★★★
  
  ★★★★★
- (90)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible